CD8A and neoplasm: showed in in vivo mouse models that tumor‐associated myeloid cells can modify the TCR via generation of reactive oxygen species and peroxynitrite resulting in loss of ability of CD8+ T cells to bind to MHC, thereby inhibiting the antigen‐specific T‐cell response 33.